BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 12411220)

  • 1. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
    Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
    Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis.
    Chwastiak LA; Gibbons LE; Ehde DM; Sullivan M; Bowen JD; Bombardier CH; Kraft GH
    J Psychosom Res; 2005 Nov; 59(5):291-8. PubMed ID: 16253619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis.
    Bamer AM; Cetin K; Johnson KL; Gibbons LE; Ehde DM
    Gen Hosp Psychiatry; 2008; 30(4):311-7. PubMed ID: 18585533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social anxiety in a multiple sclerosis clinic population.
    Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
    Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
    Tan-Kristanto S; Kiropoulos LA
    Psychol Health Med; 2015; 20(6):635-45. PubMed ID: 25588098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral classifications of chronic pain in patients with multiple sclerosis.
    Khan F; Pallant JF; Amatya B; Young K; Gibson S
    Int J Rehabil Res; 2011 Sep; 34(3):235-42. PubMed ID: 21642854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive Symptoms and Suicidal Ideation in Progressive Multiple Sclerosis Compared With Relapsing-Remitting Multiple Sclerosis: Results From a Cross-sectional Survey.
    Knowles LM; Esselman EC; Turner AP; Phillips KM; Herring TE; Alschuler KN; Ehde DM
    Arch Phys Med Rehabil; 2021 Apr; 102(4):694-701. PubMed ID: 33080210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of sleep disturbances in multiple sclerosis patients.
    Leonavicius R; Adomaitiene V
    Psychiatr Danub; 2014 Sep; 26(3):249-55. PubMed ID: 25191772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis.
    van der Werf SP; Evers A; Jongen PJ; Bleijenberg G
    Mult Scler; 2003 Feb; 9(1):89-94. PubMed ID: 12617274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity, social support, and depression: possible independent and indirect associations in persons with multiple sclerosis.
    Suh Y; Weikert M; Dlugonski D; Sandroff B; Motl RW
    Psychol Health Med; 2012; 17(2):196-206. PubMed ID: 21781021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety disorders and their clinical correlates in multiple sclerosis patients.
    Korostil M; Feinstein A
    Mult Scler; 2007 Jan; 13(1):67-72. PubMed ID: 17294613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.
    Lester K; Stepleman L; Hughes M
    J Behav Med; 2007 Apr; 30(2):177-86. PubMed ID: 17318458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics
    Holland DP; Schlüter DK; Young CA; Mills RJ; Rog DJ; Ford HL; Orchard K;
    Mult Scler Relat Disord; 2019 Jan; 27():214-222. PubMed ID: 30412819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
    Ensari I; Motl RW; McAuley E; Mullen SP; Feinstein A
    Mult Scler; 2014 Apr; 20(5):602-9. PubMed ID: 24067897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of depression and correlates of depressive symptoms for residents in the urban part of Jeju Island, Korea.
    Kim MD; Hong SC; Lee CI; Kwak YS; Shin TK; Jang YH; Oh EH; Lee JW; Jeon BH; Hwang SE
    Int J Soc Psychiatry; 2007 Mar; 53(2):123-34. PubMed ID: 17472086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of neuropathic pain in early multiple sclerosis.
    Heitmann H; Biberacher V; Tiemann L; Buck D; Loleit V; Selter RC; Knier B; Tölle TR; Mühlau M; Berthele A; Hemmer B; Ploner M
    Mult Scler; 2016 Aug; 22(9):1224-30. PubMed ID: 26480924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived mental health and disablement of primary care and end-stage renal disease patients.
    Parkerson GR; Gutman RA
    Int J Psychiatry Med; 1997; 27(1):33-45. PubMed ID: 9565712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship among performance of instrumental activities of daily living, self-report of quality of life, and self-awareness of functional status in individuals with multiple sclerosis.
    Goverover Y; Chiaravalloti N; Gaudino-Goering E; Moore N; DeLuca J
    Rehabil Psychol; 2009 Feb; 54(1):60-68. PubMed ID: 19618704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.